<DOC>
	<DOCNO>NCT01329042</DOCNO>
	<brief_summary>Extracorporeal shock wave lithotripsy ( ESWL ) Percutaneous nephrolithotomy ( PCNL ) become therapy choice renal stone . Although provide good result , stone recurrence usually find therapy change underlie metabolic abnormality . Among metabolic disorder , hypocitraturia important risk factor calcium nephrolithiasis . This study evaluate preventive effect potassium sodium citrate stone recurrence well stone growth post ESWL PCNL , patient calcium-containing stone .</brief_summary>
	<brief_title>Efficacy Potassium Sodium Hydrogen Citrate Therapy Renal Stone Recurrence and/or Residual Fragments After Shockwave Lithotripsy Percutaneous Nephrolithotomy Calcium Oxalate Urolithiasis</brief_title>
	<detailed_description />
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>age &gt; 18 year stone free residual calcium oxalate stone fragment less 4 mm . diameter eight week ESWL PCNL renal tubular obstruction serum creatinine &gt; 2 mg/dl urinary tract infection ( bacteria &gt; 100,000 urine culture ) hypersensitive contraindication Potassium sodium hydrogen citrate insertion DoubleJ Stent history arrhythmia , myocardial infarction digitalis administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Potassium sodium citrate</keyword>
	<keyword>stone recurrence</keyword>
	<keyword>ESWL</keyword>
	<keyword>PCNL</keyword>
	<keyword>Hypocitraturia</keyword>
	<keyword>intervention</keyword>
</DOC>